MY185444A - Enterovirus 71 antiviral peptides - Google Patents
Enterovirus 71 antiviral peptidesInfo
- Publication number
- MY185444A MY185444A MYPI2013700382A MYPI2013700382A MY185444A MY 185444 A MY185444 A MY 185444A MY PI2013700382 A MYPI2013700382 A MY PI2013700382A MY PI2013700382 A MYPI2013700382 A MY PI2013700382A MY 185444 A MY185444 A MY 185444A
- Authority
- MY
- Malaysia
- Prior art keywords
- enterovirus
- peptides
- antiviral
- pertains
- antiviral peptides
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 241001529459 Enterovirus A71 Species 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title abstract 3
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention pertains to peptides derived from the capsid protein of Enterovirus 71 which have antiviral activity. Also provided are pharmaceutical compositions, comprising these peptides, nucleic acids encoding the same, as well as vectors and host cells expressing the antiviral peptides of the invention. The invention also pertains to methods for treating or preventing infectious diseases caused by viruses, in particular by Picornaviruses, such as Enterovirus 71.(Figure 1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700382A MY185444A (en) | 2013-03-11 | 2013-03-11 | Enterovirus 71 antiviral peptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700382A MY185444A (en) | 2013-03-11 | 2013-03-11 | Enterovirus 71 antiviral peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY185444A true MY185444A (en) | 2021-05-19 |
Family
ID=80932697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2013700382A MY185444A (en) | 2013-03-11 | 2013-03-11 | Enterovirus 71 antiviral peptides |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY185444A (en) |
-
2013
- 2013-03-11 MY MYPI2013700382A patent/MY185444A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500709A1 (en) | Anti-lag-3 antibodies and methods of use thereof | |
| PH12018501055A1 (en) | Cpg reduced factor viii variants, compositions and methods and uses for treatment of hemostasis disorders | |
| BR112016020688A2 (en) | COMPOSITIONS USEFUL IN THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC) | |
| PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
| MX2020006117A (en) | Targeted integration of nucleic acids. | |
| PH12017502424A1 (en) | Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| MX354516B (en) | Vectors encoding rod-derived cone viability factor. | |
| PH12017501836A1 (en) | Production of oversized adeno-associated vectors | |
| EP4349404A3 (en) | Respiratory virus vaccines | |
| MX2018006840A (en) | TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs). | |
| EA201692359A1 (en) | COMPOSITION BASED ON NEW PRRSV STRAIN OR HIS PROTEINS, PRODUCT, THEIR USE, PRRSV VIRUS, ISOLATED NK AND A RECOMBINANT VECTOR OF EXPRESSION FOR OBTAINING THIS VIRUS | |
| MX372992B (en) | ADENO-ASSOCIATED VIRUS VECTOR. | |
| WO2016046234A3 (en) | Recombinant phe-free proteins for use in the treatment of phenylketonuria | |
| MD20150062A2 (en) | Antivirus compounds | |
| NZ630869A (en) | Compositions and methods for dengue virus chimeric constructs in vaccines | |
| PH12016502554B1 (en) | A dengue virus chimeric polyepitope composed of fragments of non structural proteins and its use in an immunogenic composition against dengue virus infection | |
| IN2015DN02546A (en) | ||
| PH12013502177A1 (en) | Hepatitis c virus inhibitors | |
| SG10201805197VA (en) | Compositions and methods using capsids resistant to hydrolases | |
| IN2015DN03206A (en) | ||
| PH12020550483A1 (en) | Anti-apoc3 antibodies and methods of use thereof | |
| PH12017500820A1 (en) | Combination long acting compositions and methods for hepatitis c | |
| EA201790778A1 (en) | PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FROM HEPATITIS C | |
| MY185444A (en) | Enterovirus 71 antiviral peptides | |
| MY188494A (en) | High-growth enterovirus 71 strains and vaccines |